Ophthalmic manifestations suggesting Kearns--Sayre Syndrome among young adults with cardiac conduction defects (RCD code: III-1A.5a)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2016, Vol 3, Issue 1
Abstract
Kearns-Sayre Syndrome is a multisystemic mitochondrial cytopathy characterized by specific ophthalmic signs, cardiac conduction disturbances with endocrine, musculoskeletal and central nervous system involvement. As a highly heterogeneous condition, establishing an accurate diagnosis of this disorder can often be seriously delayed. It usually occurs before the age of 20 with ocular symptoms at first. Cardiac manifestations include progressive degeneration of the conduction tissue, leading to different types of conduction disturbances, which in many cases are responsible for significant decrease of life expectancy. There is currently no causative therapy available for Kearns-Sayre Syndrome patients. Several interventions including ophthalmic or neurological may be necessary in order to improve the quality of life, however improving prognosis in this group of patients impose prompt recognitions of those, who require early pacemaker implantation. Therefore, the aim of this article is to review the current knowledge about Kearns-Sayre Syndrome in light of the most typical ophthalmic findings, which can handily be detected by cardiologists and applied to accelerate accurate diagnosis and elaborate the most appropriate therapeutic strategies. JRCD 2016; 3 (1): 5–8
Authors and Affiliations
Magdalena Karwat - Szwabowicz, Jagoda Miszczyk
Keywords
Related Articles
- EP ID EP244132
- DOI 10.20418/jrcd.vol3no1.257
- Views 129
- Downloads 0
Doxorubicin cardiomyopathy – case report and review of histopathologic findings (RCD code: III‐1B.5a)
The anthracycline anticancer drug Doxorubicin (Adriamycin) is an effective and frequently used chemotherapeutic agent for various malignancies. The use of doxorubicin is limited by its major adverse effect, cardiotoxicit...
Different biochemical profile of stable and decompensated systolic heart failure patients due to ischemic or dilated cardiomyopathy hospitalized in the tertiary cardiology center (RCD code: III-1)
Aim: This study aims to compare the extended biochemical profile of unselected and consecutive systolic heart failure (SHF) patients admitted electively and urgently to the tertiary cardiology center. Methods: This study...
Biventricular cardiomyopathy improvement by shifting therapy from agalsidase alfa to agalsidase beta in Anderson‐Fabry Disease
Treatment of Fabry disease has improved since the introduction of enzyme replacement therapy (ERT). Two preparations of the recom‐ binant enzyme α‐galactosidase A are available: agalsidase alfa and agalsidase beta. We ai...
Third Conference of the Pulmonary Circulation Task Force of the Polish Cardiac Society
Third Conference of the Pulmonary Circulation Task Force of the Polish Cardiac Society was held on 8th‑9th November 2013 in Golebiewski Hotel in Bialystok. The Scientific Committee of the Conference constituted Prof. Mar...
Long‑term experience in patients undergoing endovascular revascularization procedures for symptomatic Takayasu arteritis (RCD code: I-3A.1)
Takayasu arteritis (TA) is often manifested by a prolonged limb claudication, renovascular hypertension or a sudden ischemic stroke (IS) or myocardial infarction (MI) occurring in young adults. The study aimed to assess...